Dopavision
1 follower
The goal of the Berlin-based startup is to develop a clinically validated therapy for myopia progression in children and adolescents. The technology delivers light stimulation to specific photosensitive cells on the retina which in turn modulate dopamine, a neurotransmitter that is important for the... Read more
Org chart
Mark Wuttke
Chief Executive Officer
Mark Wuttke
Collapse
Andreas Balser
Chief Technology Officer
Gabriela Burian
Consulting Chief Medical Officer
Hamed Bahmani
Founder
Vicky Gravia
Strategy and Operations Manager
Stefan Zundel
Co-Founder
Dr. Tim Schilling
Translational Science Director
